Daily Brief Australia: oOh!Media Ltd, Rio Tinto Ltd, Betmakers Technology Group , Prescient Therapeutics, Ardent Leisure Group, Aureka Limited, Agrimin Ltd, Avjennings Ltd, Amotiv, Avenira Ltd and more

• The AFR reports that I Squared emerged with a winning binding proposal for oOh!Media Ltd (OML AU) at A$1.70, a 100.0% premium to the undisturbed price of A$0.85 (28 April).
• The offer is light compared to peer and precedent transactions and is below the 52-week high of A$1.73.
• However, shareholders should be supportive, as the offer was the highest in a competitive auction, and it is uncertain whether the Board’s strategic execution could outperform a 100% takeover premium.

• Australia’s ASIC releases the aggregated short position data four business days after the reporting day. Data in this insight is up to 3rd August, published on the 7th August.
• The largest industry net increase in the past week was A$0.1bn into “Metals“; the largest industry net decrease was A$0.1bn out of “Food Retail“. Net shorts increased A$0.6bn week-on-week.
• Companies mentioned in this regular weekly report include: Rio Tinto Ltd (RIO AU), Wisetech Global (WTC AU), Ampol (ALD AU), DroneShield Ltd (DRO AU), and Develop Global (DVP AU).

• This morning (10th August), gambling tech play BetMakers (BET AU)announced it had entered into an offer, by way of a Scheme, with Tabcorp (TAH AU), at A$0.24/share, in cash.
• That’s a 45.5% premium to undisturbed. BetMakers’ shareholders can also elect scrip (25%/50%/75%/100%) with the balance in cash. Scrip is capped. The default option is cash.
• BetMakers’ board, holding ~10% of shares out, unanimously support terms. Completion targeted 3Q27 (Jan-Mar’ 27). ACCC approval required. That’s the wild card.

• Prescient Therapeutics is a clinical-stage oncology company with a dual-focus pipeline: targeted small-molecule drugs (PTX-100 and PTX-200) and next-generation cell therapy platforms (OmniCAR and CellPryme).
• The company is pre-revenue and its valuation is contingent on the successful clinical development, regulatory approval, and eventual commercialization of its assets. Key near-term catalysts are tied to the progress of the PTX-100 Phase 2a trial in T-cell lymphomas.
• Investment in Prescient carries high intrinsic risk associated with clinical trial outcomes, regulatory hurdles, and the need for future financing, balanced against the significant potential market opportunity for novel, effective cancer therapies.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• Focused Australian Leisure Operator: Following the sale of its US-based Main Event business in June 2022, Ardent Leisure has streamlined its operations to focus on its portfolio of Australian theme parks and attractions, including Dreamworld, WhiteWater World, and SkyPoint. This has resulted in a simplified corporate structure and a strengthened balance sheet, allowing for reinvestment in its core assets.
• Strong Post-Pandemic Recovery: The company has demonstrated a significant rebound in financial performance following the easing of COVID-19 restrictions. For the fiscal year ended June 27, 2023, the Theme Parks and Attractions business reported a 70% increase in revenue to $83.9 million and the first positive EBITDA since 2016. This recovery has been driven by a 39% increase in attendance and a 22% rise in per capita spending.
• Strategic Growth Initiatives: Future growth is expected to be driven by a multi-faceted strategy that includes investment in new rides and attractions to enhance the guest experience, the development of surplus land at the Dreamworld precinct, and a continued focus on operational efficiencies and safety. The company is well-capitalized to fund these initiatives.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• Aureka is a pre-revenue junior exploration company focused on high-grade gold projects in the historically significant goldfields of Victoria, Australia.
• The company’s primary strategic driver is the expansion of its JORC-compliant resource base, highlighted by recent successful drilling at its flagship Irvine project.
• Key catalysts include ongoing drilling results and the potential for a faster, lower-capital pathway to production through partnerships with local mill owners for its Comstock project.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• Recent strategic review has concluded the flagship Mackay Potash Project is uneconomic under current and foreseeable conditions, leading to a withdrawal from the project.
• The company is pivoting its focus to the exploration of non-potash minerals, specifically in the West Arunta region of Western Australia, leveraging its existing tenements in the area.
• Agrimin is now a high-risk exploration entity with minimal project-related holding costs, a small cash balance, and strategic investments in other resource companies, facing significant uncertainty and a fundamental shift in its business model.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• AVJennings has demonstrated a significant deterioration in financial performance, with net income and operating cash flow declining sharply over the past three years, culminating in a net loss and substantial negative cash flow in the most recent period.
• The company’s growth trajectory is deeply negative across key metrics, including market cap, net income, and EPS over 3, 5, and 7-year periods, reflecting prolonged operational and market-based challenges.
• Facing a cooling Australian housing market with forecasted price declines in major cities for 2026, the company’s outlook is challenged by rising interest rates, affordability pressures, and persistent cost inflation, although a modest recovery is anticipated in 2027.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• Amotiv‘s valuation appears attractive, trading at a significant discount to peers across key metrics; however, this is overshadowed by a severe deterioration in profitability, culminating in a substantial net loss in FY25.
• The company faces significant competitive pressures in the Australian automotive aftermarket from larger, more scaled rivals, making operational efficiency and strategic niche positioning critical for future success.
• Despite the recent earnings collapse, Amotiv has maintained stable operating cash flow and a consistent dividend, though the sustainability of the payout is a key concern given the lack of profitability.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.

• Avenira is transitioning from a pure exploration entity to a project developer, with a near-term focus on generating revenue from its Wonarah Direct Shipping Ore (DSO) phosphate project in the Northern Territory, one of Australia’s largest phosphate deposits.
• The company’s long-term strategy is centered on vertical integration, aiming to move downstream into the production of higher-value products such as yellow phosphorus (YP), thermal phosphoric acid (TPA), and potentially Lithium Ferro Phosphate (LFP) battery cathode materials, tapping into the growing demand from both the agricultural and electric vehicle sectors.
• While the strategic pivot to value-added products presents significant growth potential, the company faces considerable execution risks, including securing funding, finalizing logistics, and navigating the complexities of downstream processing, as highlighted by the recent termination of its L-F-P technology agreement with Aleees.

This content is AI-generated and displayed for general informational purposes only. Please verify independently before use.